Control of warfarin therapy.
作者信息
Scott D K
机构信息
West Birmingham Health Authority, Dudley Road Hospital, Birmingham, UK.
出版信息
Postgrad Med J. 1989 Sep;65(767):611-2. doi: 10.1136/pgmj.65.767.611.
Abstract
摘要
相似文献
1
Control of warfarin therapy.华法林治疗的控制
Postgrad Med J. 1989 Sep;65(767):611-2. doi: 10.1136/pgmj.65.767.611.
2
Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin.丹参-葛根配方诱导肝脏细胞色素P450是其与华法林发生药代动力学相互作用的主要原因。
J Ethnopharmacol. 2014 Jul 3;154(3):672-86. doi: 10.1016/j.jep.2014.04.047. Epub 2014 May 14.
3
[Fifty years of clinical use of warfarin].[华法林五十年的临床应用]
Invest Clin. 2010 Jun;51(2):269-87.
4
Warfarin therapy. 2.
N Engl J Med. 1970 Oct 8;283(15):801-3. doi: 10.1056/NEJM197010082831508.
5
Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.在患有癌症的儿童中，华法林的口服抗凝作用受类固醇和CYP2C9基因多态性的显著影响。
Pediatr Blood Cancer. 2008 Mar;50(3):710-3. doi: 10.1002/pbc.21133.
6
Current concepts of warfarin therapy.
Arch Intern Med. 1986 Mar;146(3):581-4.
7
Patient factors that influence warfarin dose response.影响华法林剂量反应的患者因素。
J Pharm Pract. 2010 Jun;23(3):194-204. doi: 10.1177/0897190010362177. Epub 2010 May 6.
8
Tailoring warfarin induction doses to reflect individual and disease-specific factors.
Am J Med. 2005 Feb;118(2):143-4. doi: 10.1016/j.amjmed.2004.11.015.
9
Transition from acenocoumarol to warfarin in a 12-year-old child.一名12岁儿童从醋硝香豆素转换为华法林的过程。
Congenit Heart Dis. 2011 Nov-Dec;6(6):661-4. doi: 10.1111/j.1747-0803.2011.00516.x. Epub 2011 Apr 19.
10
Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models.使用个体狨猴生理药代动力学模型，研究手性分离的R-奥美拉唑和S-华法林的体内肝脏清除率与多态性狨猴细胞色素P450 2C19的相关性。
Xenobiotica. 2018 Oct;48(10):1072-1077. doi: 10.1080/00498254.2017.1393121. Epub 2017 Nov 10.
引用本文的文献
1
Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.普通诊所患者与医院抗凝门诊患者抗凝控制情况的比较。
Br J Gen Pract. 1993 Apr;43(369):152-4.
本文引用的文献
1
Lack of effect of fortified wine ingested during fasting and anticoagulant therapy.空腹及抗凝治疗期间饮用强化葡萄酒无效。
Arch Intern Med. 1981 Mar;141(4):458-9.
2
Prenatal development of lumbar intervertebral articulation.腰椎椎间关节的产前发育
Folia Morphol (Praha). 1982;30(3):285-90.
3
Effect of posture and drink volume on the swallowing of capsules.姿势和饮水量对胶囊吞咽的影响。
Br Med J (Clin Res Ed). 1982 Dec 11;285(6356):1702. doi: 10.1136/bmj.285.6356.1702.
4
Drug interaction with coumarin derivative anticoagulants. Standing Advisory Committee for Haematology of the Royal College of Pathologists.药物与香豆素衍生物抗凝剂的相互作用。皇家病理学家学院血液学常设咨询委员会。
Br Med J (Clin Res Ed). 1982 Jul 24;285(6337):274-5. doi: 10.1136/bmj.285.6337.274.
5
Therapeutic ranges in anticoagulant administration.抗凝治疗的治疗范围。
Br Med J (Clin Res Ed). 1985 Jun 8;290(6483):1683-6. doi: 10.1136/bmj.290.6483.1683.
6
Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
Clin Pharm. 1985 Jul-Aug;4(4):440-6.
7
Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.华法林治疗初始院内稳定期三种剂量预测方法的评估。
Clin Pharm. 1987 Jan;6(1):37-45.
8
Anticoagulants in venous thromboembolism.静脉血栓栓塞中的抗凝剂。
BMJ. 1988 Nov 19;297(6659):1285-8. doi: 10.1136/bmj.297.6659.1285.
9
Laboratory control of oral anticoagulants.口服抗凝剂的实验室监测
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1184. doi: 10.1136/bmj.294.6581.1184.
10
Intermittent absorption of warfarin caused by an unrecognized pharyngeal pouch.未被识别的咽囊导致华法林吸收间歇性异常。
Postgrad Med J. 1989 Sep;65(767):660-1. doi: 10.1136/pgmj.65.767.660.
Zotero 插件